Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

SZSE Ticker: 300858

Beijing Scitop Bio-tech Co., Ltd.

北京科拓恒通生物技术股份有限公司

科拓生物

SCITOP BIO

Listing Date: 2020-07-27

Board: GEM

Industry Classification: Manufacturing

Ketuo Bio: Except for Jinhua Galaxy, the operating financial data of the company's other subsidiaries have not yet met the disclosure standards

  • Post date May 14, 2022 — 12:23 Post Lock Login to View

Read More

Ketuo Bio: Except for Jinhua Galaxy, the operating financial data of the company's other subsidiaries have not yet reached the disclosure standard_Oriental Fortune Net

  • Post date May 14, 2022 — 12:23 Post Lock Login to View

Read More

The top ten transaction list of northbound capital trading on May 11

  • Post date May 11, 2022 — 18:40 Post Lock Login to View

Read More

Ketuo Bio: The proportion of raw materials used in different product formulations of the company's edible probiotic products is different

  • Post date May 11, 2022 — 12:14 Post Lock Login to View

Read More

Ketuo Bio: The company's edible probiotic products have different product formulas and different proportions of raw materials used.

  • Post date May 11, 2022 — 12:14 Post Lock Login to View

Read More

Ketuo Bio: The company has cooperated with many tertiary hospitals such as West China Hospital of Sichuan University, People's Hospital of Inner Mongolia Autonomous Region, Beijing Shijitan Hospital, etc.

  • Post date May 5, 2022 — 14:42 Post Lock Login to View

Read More

Ketuo Bio: The company has cooperated with many tertiary hospitals such as West China Hospital of Sichuan University, People's Hospital of Inner Mongolia Autonomous Region, Beijing Shijitan Hospital, etc.

  • Post date May 5, 2022 — 14:42 Post Lock Login to View

Read More

The Top 10 Transaction List of Northbound Fund Trading on April 29

  • Post date April 29, 2022 — 19:32 Post Lock Login to View

Read More

Tianfeng Securities gives Ketuo Bio a buy rating: probiotics business maintains a high growth trend, and R&D barriers are built to lead the industry

  • Post date April 29, 2022 — 12:40 Post Lock Login to View

Read More

Tianfeng Securities assigns a buy rating to Ketuo Bio: Probiotics business maintains a high growth trend, and R&D barriers are built to lead the industry – yqqlm

  • Post date April 29, 2022 — 12:40 Post Lock Login to View

Read More

Guohai Securities maintains Ketuo Bio’s Overweight Rating Annual Report & First Quarterly Report Comments: Probiotics Sector High Growth and Overall Business Structure Continues to Optimize_Oriental Fortune Network

  • Post date April 28, 2022 — 13:56 Post Lock Login to View

Read More

Ketuo Bio's 2021 revenue and net profit will increase steadily and the edible probiotics business will increase by 129%

  • Post date April 28, 2022 — 13:30 Post Lock Login to View

Read More

Ketuo Bio's 2021 revenue and net profit will increase steadily and the edible probiotics business will increase by 129%

  • Post date April 27, 2022 — 20:46 Post Lock Login to View

Read More

Ketuo Bio: The company's probiotics are widely used in the field of daily cosmetics, such as facial masks, face creams, toothpaste, mouthwash and other products, and have been industrially applied

  • Post date April 27, 2022 — 14:13 Post Lock Login to View

Read More

Ping An Securities gives Ketuo Bio a recommendation rating: the leading domestic probiotics have high technical barriers and are ready to meet the inflection point – yqqlm

  • Post date April 24, 2022 — 13:22 Post Lock Login to View

Read More

Ping An Securities gives Ketuo Bio a recommendation rating: the leading domestic probiotics have high technical barriers and are ready to meet the inflection point – yqqlm

  • Post date April 24, 2022 — 13:22 Post Lock Login to View

Read More

The first "Ketuo Bio Cup" probiotics science knowledge contest was successfully held

  • Post date April 11, 2022 — 16:58 Post Lock Login to View

Read More

Ketuo Bio: At present, the company's production and operation are all normal, and the construction of new projects will be fully advanced according to the plan.

  • Post date April 6, 2022 — 12:15 Post Lock Login to View

Read More

Ketuo Bio: At present, the company's production and operation are all normal, and the construction of new projects will be fully advanced according to the planned progress_Oriental Fortune Network

  • Post date April 6, 2022 — 12:15 Post Lock Login to View

Read More

Ketuo Bio: At present, the company's production and operation are all normal, and the construction of new projects will be fully promoted according to the planned progress.

  • Post date April 6, 2022 — 12:14 Post Lock Login to View

Read More

  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.